TREM2 and Alzheimer disease: Compared with homeostatic microglia, DAMs exhibited reduced expression of core microglial genes (P2ry12, Tmem119, Csf1r, and Cx3cr1) and increased expression of AD risk genes (Apoe, Lpl, Trem2, Tyrobp, and Ctsd), suggesting that DAMs may directly affect disease progression.